Nanoviricides NNVC
NYSE NNVC
$1.51 +0.03 (+2.03%)
As of: Oct 21, 2026 · 3:59 PM EDT

Nanoviricides (NNVC) Other financing activities (2019 - 2021)

Updated

Nanoviricides' Other financing activities was $37,408 in fiscal Q2 2022 (quarter ended Dec 31, 2021), compared with -$41,024 a year earlier.

Analysis

Nanoviricides (NNVC) Other financing activities (2019 - 2021) Analysis & Trends

For FY2020 (ended Jun 30, 2020), Other financing activities at Nanoviricides came in at $12,190.

  • The fiscal Q2 2022 figure marks the highest quarterly Other financing activities since fiscal Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Nanoviricides 30.18 Mn 17.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -37,408.00
Dec 31, 2020 41,024.00
Sep 30, 2020 -41,024.00
Dec 31, 2019 -141,070.00
Sep 30, 2019 -242,105.00
API Access

Nanoviricides Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=NNVC&period=max&api_key=YOUR_API_KEY